Nuvisan Gmbh | FDA | Inspections | Form 483 | Warning Letters | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Nuvisan GmbH
FDA

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Nuvisan GmbH

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Corporate Presentation

Corporate Presentation

DIGITAL CONTENT

INTERVIEW #SpeakPharma, VLOG #PharmaReel, DATA COMPILATION #PharmaFlow, 2 NEWS #PharmaBuzz

INTERVIEW #SpeakPharma
VLOG #PharmaReel
DATA COMPILATION #PharmaFlow
2 NEWS #PharmaBuzz

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

SERVICES

Analytical, Clinical Trials, API & Drug Product Development

Analytical
- 1 Analytical Testing Services
- 3 BioAnalytical Services
Clinical Trials
API & Drug Product Development
- 1 Formulation Development

INSPECTIONS & REGISTRATIONS

2 FDA

2 FDA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Legal Name Reset all filters

2 All

01 2Nuvisan GmbH

filter District Decision Reset all filters

2 All

01 1No Action Indicated

02 1Voluntary Action Indicated

filter Inspection End Date Reset all filters

2 All

01 12014-07-25

02 12012-05-16

filter City Reset all filters

2 All

01 2Neu-Ulm

filter Country/Area Reset all filters

2 All

01 2DE

Supplier Virtual Booth

price-trend

01

FDA Audited

USA

Biotech Digital Meet

Not Confirmed

FDA Audited

USA

Biotech Digital Meet

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2014-07-25

Nuvisan GmbH

City : Neu-Ulm

State :

Country/Area : DE

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2014-07-25

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

FDA Audited

USA

Biotech Digital Meet

Not Confirmed

FDA Audited

USA

Biotech Digital Meet

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2012-05-16

Nuvisan GmbH

City : Neu-Ulm

State :

Country/Area : DE

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2012-05-16

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!